Previous 10 | Next 10 |
FORT WORTH, Texas, Aug. 17, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (the “Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology plat...
2023-08-15 16:51:09 ET TFF Pharmaceuticals, Inc. (TFFP) Q2 2023 Results Conference Call August 15, 2023 11:00 AM ET Company Participants Corey Davis - IR, LifeSci Advisors Dr. Harlan Weisman - CEO Dr. Zamaneh Mikhak - Chief Medical Officer Kirk Coleman - CFO ...
2023-08-15 14:26:44 ET Penny stocks provide a captivating opportunity for those aiming to profit in the stock market. The intrinsic risk and potential rewards associated with these stocks often lead to intense speculation and a quest for remarkable profits. It’s not uncommon to witne...
2023-08-15 06:36:10 ET More on TFF Pharmaceuticals TFF Pharma wins nearly $3M grant to develop universal flu shot TFF Pharma slips 22% on $10.68M public offering TFF Pharma plunges 39% after updating timeline for Phase 2 data readouts Seeking Alpha’s Q...
2023-08-15 06:18:58 ET More on TFF Pharmaceuticals TFF Pharma wins nearly $3M grant to develop universal flu shot TFF Pharmaceuticals reports Q4 results TFF Pharma slips 22% on $10.68M public offering TFF Pharma plunges 39% after updating timeline for Phase 2...
Announced pricing of approximately $5 million equity financing (approximately $5.7 million if underwriter’s overallotment option is exercised in full); expected to extend cash runway through initial clinical data readouts and first quarter 2024 >80% of TFF VORI clinical sites ...
FORT WORTH, Texas, Aug. 15, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (the “Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology plat...
FORT WORTH, Texas, Aug. 14, 2023 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (the “Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology plat...
2023-08-14 11:10:10 ET TFF Pharmaceuticals ( NASDAQ: TFFP ) is scheduled to announce Q2 earnings results on Tuesday, August 15th, before market open. The consensus EPS Estimate is -$0.20 (+41.2% Y/Y) and the consensus Revenue Estimate is $0.1M (-99.6% Y/Y). For further d...
2023-08-14 10:17:31 ET Major earnings expected before the bell on Tuesday include: Cardinal Health ( CAH ) The Home Depot ( HD ) Jumia Technologies ( JMIA ) Seadrill ( SDRL ) Sea ( SE ) For further details see: Notable earnings before Tues...
News, Short Squeeze, Breakout and More Instantly...
TFF Pharmaceuticals Inc - Ordinary Shares Company Name:
TFFP Stock Symbol:
NYSE Market:
TFF Pharmaceuticals Inc - Ordinary Shares Website:
FORT WORTH, Texas, June 26, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology plat...
FDA Provided Constructive Feedback to Help Guide Next Steps in TFF TAC Clinical Development Company to Provide More Detailed Regulatory Update in 3Q 2024 FORT WORTH, Texas, June 24, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP) (“the Company”), a ...